Clinical Updates

Just weeks after completing its $3.6 billion purchase of King Pharmaceuticals, Pfizer Inc has recalled an opioid painkiller obtained in… »   

A Purdue University scientist’s nanopolymer would make it easier and cheaper for drug developers to test the effectiveness of a… »   

Scientists have shown that an experimental vaccine against the human norovirus – the bug behind about 90 percent of highly… »   

A new laser technique has demonstrated it can measure the interactions between proteins tangled in a cell’s membrane and a… »   

Novartis AG’s blood cancer drug INC424 could rake in annual sales of $1 billion, the group’s head of oncology told… »   

Prices for prescription drugs rose at a faster rate than costs for other medical goods and services over the last… »   

Medtronic Inc said on Wednesday it resolved two warning letters issued by U.S. health regulators in 2009, clearing the way… »   

A group of researchers from EPFL’s Global Health Institute (GHI) and Inserm (Institut National de la Santé et de la… »   

A prolific University of Missouri chemist has discovered a quicker and easier method for pharmaceutical companies to make certain drugs.

Fumaric acid salts have been in use against severe psoriasis for a long time. About ten years ago, researchers in… »   

Japan’s health ministry halted the use of vaccines made by Pfizer Inc and Sanofi-Aventis SA that prevent meningitis and pneumonia… »   

The Supreme Court let stand a ruling that drug companies can pay rivals to delay production of generic drugs without… »   

Human Genome Sciences Inc’s lupus drug is poised to win clearance this week, offering patients the first approved treatment option… »   

A new study finds that a brain rhythm considered the hallmark of wakefulness not only persists inconspicuously during sleep but… »   

Today the Food and Drug Administration (FDA) announced that 500 prescription drugs used to treat colds, coughs and allergies will… »